Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with an annual incidence
of~ 1 case per million population. Differentiating between ACC and benign adrenocortical …

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis, the five-years
overall survival being below 40%. However, there is great variability of outcomes and we …

Context Adrenocortical carcinoma (ACC) has a heterogeneous prognosis, and current
medical therapies have limited efficacy in its advanced stages. Genome-wide multiomics …

Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with high risk of
recurrence despite macroscopically complete surgical resection. The main predictors of …

Background Open adrenalectomy is considered a standard operative approach for
adrenocortical carcinoma, and laparoscopic adrenalectomy remains controversial. We …

Context Reporting temporal trends in adrenocortical carcinoma (ACC) helps guide
management strategies. Objective This work aimed to report the trends in disease burden …

Background: The aim of this study was to review the current literature on the role of
laparoscopic adrenalectomy (LA) in the treatment of primary adrenocortical carcinoma …

Introduction: Adrenocortical carcinoma (ACC) is a rare tumor, often discovered at an
advanced stage and associated with poor prognosis. Treatment is guided by staging …

Compared to benign adrenal lesions, secreting or otherwise, malignant adrenocortical
carcinoma is rare. Overall prognosis is poor, with< 50% 5-year survival. Various prognostic …